Applications open in November for MOGA’s 5th Australia & Asia Pacific Clinical Research Development (ACORD) Workshop.
Held from 9 to 15 September 2012, MOGA will present the workshop with its collaborating partners, the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), American Association for Cancer Research, Cancer Council of Australia and Clinical Oncological Society of Australia.
ACORD is open to advanced trainees, junior clinicians and younger-mid career consultants working across all oncology specialities and related allied health professions, with an interest in developing their expertise in clinical trials design and research.
The program offers oncology professionals a unique one week residential training program and is the Asia-Pacific region’s version of the highly regarded Flims and Vail Programs run respectively by European Society for Medical Oncology and American Society of Clinical Oncology.
Applicants are required to submit an outline of a research concept or protocol for a clinical trial that they wish to develop during and after the workshop. Sixty successful applicants from the Asia Pacific region will join an internationally renowned faculty of cancer specialists from around the globe.
Applications for the 2012 program open on 7 November and can be submitted online. For details visit www.acordworkshop.org.au or call MOGA on 02 9256 9651.
The new Chairman of the MOGA, Associate Professor Gary Richardson, took up his position in early August after Associate Professor Michael Michael stepped down.
Professor Richardson stated that MOGA was at an important stage in its history with an ever-strengthening voice in advocating and lobbying on key oncology drug and treatment issues to benefit both patients and clinicians nationally, in addition to managing a range of important educational and professional programs.
MOGA held its 2011 Annual Scientific Meeting in Adelaide in August. The meeting examined advances in cancer care cost and value and considered the economic challenges associated with cancer care, along with sessions on the latest developments in lung cancer, colorectal cancer and neuroendocrine tumours.
The meeting was followed by the Best of ASCO Australia program, providing attendees with another forum in which to examine emerging international developments in oncology, in the Australian context.